Page last updated: 2024-10-28

halothane and Encephalopathy, Hepatic

halothane has been researched along with Encephalopathy, Hepatic in 41 studies

Research Excerpts

ExcerptRelevanceReference
" We present a case report wherein a person who sustained avulsion injury to his left hand in an industrial accident, died due to, fulminant hepatitis, hepatic encephalopathy and acute renal failure, having undergone six operations under general anesthesia with halothane during his stay in the hospital."3.73Fulminant hepatic failure following halothane anaesthesia. ( Bhat, VJ; Kumar, GP; Sowdi, V, 2005)
"Halothane antibodies were detected in 12 of the 16 (75%) patients with hepatic encephalopathy and 16 of the 23 (70%) who did not develop encephalopathy, demonstrating that halothane antibodies are detectable in a wider spectrum of halothane-associated liver damage than previously appreciated."1.27Specific antibodies to halothane-induced liver antigens in halothane-associated hepatitis. ( Kenna, JG; Neuberger, J; Williams, R, 1987)
"3."1.25Exchange transfusion in hepatic coma: factors affecting results, with long-term follow-up data. ( Darin, JC; Hussey, CV; Lewis, JD; Varma, RR, 1975)

Research

Studies (41)

TimeframeStudies, this research(%)All Research%
pre-199032 (78.05)18.7374
1990's7 (17.07)18.2507
2000's2 (4.88)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kumar, GP1
Bhat, VJ1
Sowdi, V1
Burnell, JM2
Dawborn, JK1
Epstein, RB1
Gutman, RA1
Leinbach, GE1
Thomas, ED2
Volwiler, W2
Sasaki, H1
Inoue, K1
Canalese, J1
Wyke, RJ1
Vergani, D1
Eddleston, AL1
Williams, R6
Sielaff, TD1
Hu, MY1
Rollins, MD1
Bloomer, JR1
Amiot, B1
Hu, WS1
Cerra, FB1
Weber, P1
Scheurlen, M1
Irkin, I1
Viebahn, R1
Schareck, W1
Becker, W1
de Groot, H1
Lauchart, W1
Puri, AS1
Sikora, SS1
Aggarwal, R1
Naik, SR1
Elliott, RH1
Strunin, L1
Tsubota, A1
Kumada, H1
Kharasch, ED1
Hankins, D1
Mautz, D1
Thummel, KE1
Rodés, J1
Bruguera, M1
Schmidt-Wilcke, HA1
Wolfert, W1
Grundmann, E1
Di Nino, GF1
Faenza, S1
Martinelli, G1
Sparta, S1
Norton, L1
Moore, G1
Eiseman, B1
Lewis, JD1
Hussey, CV1
Varma, RR1
Darin, JC1
McIntyre, N1
Patial, RK1
Sarin, R1
Patial, SB1
O'Grady, JG1
Gimson, AE1
O'Brien, CJ1
Pucknell, A1
Hughes, RD1
Fossati, C1
Kenna, JG1
Neuberger, J1
Gazzard, BG1
Weston, MJ1
Murray-Lyon, IM1
Flax, H1
Record, CO1
Portmann, B1
Langley, PG1
Dunlop, EH1
Mellon, PJ1
Ward, MB1
Jones, EA1
Clain, D1
Clink, HM1
MacGillivray, M1
Sherlock, S1
Versieck, J1
Van Waes, L1
Barbier, F1
Demeulenaere, L1
Vermeire, P1
Naccarato, R1
Gritti, G1
Giunta, F1
Chiaramonte, M1
Valenti, F1
Lepore, MJ1
Goertz, J1
Runge, C1
Saunders, FC1
Hussey, HH1
Knell, AJ1
Davidson, AR1
Kantamaneni, BD1
Curzon, G1
Dalsgaard, M1
Andreasen, PB1
Ranek, L1
Trey, C1
Davidson, CS1
Hargrove, MD1
Rogers, AI1
Winch, J1
Caravati, CM1
Hooker, TH1
Lempinen, M1
Collan, Y1
Sivula, A1
Merikallio, E1
Salmenkivi, K1
Paloheimo, M1
Turunen, MT1
Jokinen, EJ1
Ahlqvist, J1
Peters, RL1
Edmondson, HA1
Reynolds, TB1
Meister, JC1
Curpey, TJ1
Condon, RE1
Bombeck, CT1
Steigmann, F1
McKechnie, JC1
Hersh, T1
Mihalecz, K1
Császár, J1
Thompson, EN1
Cawdery, J1
Martin, J1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Phase 2a Study to Evaluate the Safety and Tolerability of OCR-002 (Ornithine Phenylacetate) in the Treatment of Patients With Acute Liver Failure/Severe Acute Liver Injury[NCT01548690]Phase 247 participants (Actual)Interventional2012-06-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Change in Ammonia

To evaluate the effect of OCR-002 on ammonia levels in patients with acute liver failure/severe acute liver injury (NCT01548690)
Timeframe: Baseline and 72 Hours

InterventionPercent Change (Mean)
Maximum Dose Level 3.33 g/24h41.2
Maximum Dose Level 6.65 g/24h16.6
Maximum Dose Level 10 g/24h41.8
Maximum Dose Level 20g/24h38.4

Measurement of OCR-002 Plasma Concentration

To evaluate the steady state pharmacokinetic and pharmacodynamic profile of OCR-002 in patients with impaired and intact renal function using urinary phenylacetylglutamine (PAGN) as a surrogate marker (NCT01548690)
Timeframe: 24 Hours after last infusion

Interventionmicrograms per millileter (Mean)
Maximum Dose Level 3.33 g/24h65.6
Maximum Dose Level 6.65 g/24h32.2
Maximum Dose Level 10 g/24h33.4
Maximum Dose Level 20g/24h104.9

Neurological Function Measured by the Orientation Log (O-log)

The orientation log focuses on orientation to place, time, and circumstance. There are 10 items on the orientation log, which are scored 0-3. A spontaneous correct response is awarded 3 points. A spontaneous response that is lacking or incorrect, but a correct response is provided following a logical cue is awarded 2 points. A score of 1 is given if spontaneous and cued responses are lacking or incorrect, but a correct response is provided in a recognition format. A score of 0 is given if the spontaneous, cued, or recognition format does not generate a correct answer. Scores from the 10 items are summed and the final score ranges from 0 to 30. (NCT01548690)
Timeframe: 30 Days

Interventionunits on a scale (Mean)
Maximum Dose Level 3.33 g/24h23.8
Maximum Dose Level 6.65 g/24h24.0
Maximum Dose Level 10 g/24h24.0
Maximum Dose Level 20g/24h24.0

Neurological Function Measured by the West Haven Criteria (WHC) for Hepatic Encephalopathy

The West Haven Criteria (WHC) for Hepatic Encephalopathy measures the severity of encephalopathy and patient's level of consciousness. The scale ranges from 0 to 4; a minimum score of 0 represents a better outcome, and a maximum total score of 4 represents a worse outcome. A score of 0 corresponds to normal consciousness and behavior and normal neurological examination. A score of 1 corresponds to mild lack of awareness, shortened attention span, and impaired addition or subtraction; mild asterixis or tremor. A score of 2 corresponds to lethargy, disorientated or inappropriate behavior, obvious asterixis; slurred speech. A score of 3 corresponds to somnolent but arousable, gross disorientation or bizarre behavior, muscle rigidity and clonus; hyperreflexia. A score of 4 corresponds to coma and decerebrate posturing. (NCT01548690)
Timeframe: 120 hours from start of infusion

Interventionunits on a scale (Mean)
Maximum Dose Level 3.33 g/24h2.4
Maximum Dose Level 6.65 g/24h3.2
Maximum Dose Level 10 g/24h1.6
Maximum Dose Level 20g/24h1.8

Number of Participants That do Not Tolerate the Administered Dose and Had Grade 3 or 4 Treatment Emergent Adverse Events as a Measure of Safety and Tolerability

To evaluate the safety and tolerability of OCR-002 in patients with acute liver failure/severe acute liver injury (NCT01548690)
Timeframe: 30 Days

InterventionParticipants (Count of Participants)
Maximum Dose Level 3.33 g/24h0
Maximum Dose Level 6.65 g/24h0
Maximum Dose Level 10 g/24h0
Maximum Dose Level 20g/24h0

Reviews

6 reviews available for halothane and Encephalopathy, Hepatic

ArticleYear
Hepatotoxicity of volatile anaesthetics.
    British journal of anaesthesia, 1993, Volume: 70, Issue:3

    Topics: Anesthetics; Animals; Antibodies; Chemical and Drug Induced Liver Injury; Enflurane; Halothane; Hepa

1993
[Emergency drug therapy of fulminant hepatitis].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1995, Nov-10, Volume: 84, Issue:11

    Topics: Alprostadil; Amino Acids, Branched-Chain; Apoptosis; Cytokines; Emergencies; Halothane; Hepatic Ence

1995
Hepatobiliary disease: medical emergencies.
    Bailliere's clinical gastroenterology, 1991, Volume: 5, Issue:4

    Topics: Acetaminophen; Biliary Tract Diseases; Emergencies; Halothane; Hepatic Encephalopathy; Hepatitis, Vi

1991
[Toxicity and hepatotoxicity of halothane].
    La Clinica terapeutica, 1986, Mar-31, Volume: 116, Issue:6

    Topics: Drug Hypersensitivity; Halothane; Hepatic Encephalopathy; Humans; Liver

1986
The management of fulminant hepatic failure.
    Progress in liver diseases, 1970, Volume: 3

    Topics: Acute Disease; Blood Transfusion; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Hal

1970
Therapeutic considerations in selected forms of acute and chronic liver disease.
    The Medical clinics of North America, 1971, Volume: 55, Issue:2

    Topics: Acute Disease; Age Factors; Alcoholism; Azathioprine; Chemical and Drug Induced Liver Injury; Chroni

1971

Trials

2 trials available for halothane and Encephalopathy, Hepatic

ArticleYear
Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis.
    Lancet (London, England), 1996, May-18, Volume: 347, Issue:9012

    Topics: Adult; Alanine Transaminase; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome

1996
Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.
    Gastroenterology, 1988, Volume: 94, Issue:5 Pt 1

    Topics: Acetaminophen; Adolescent; Adult; Aged; Charcoal; Child; Clinical Trials as Topic; Female; Halothane

1988

Other Studies

33 other studies available for halothane and Encephalopathy, Hepatic

ArticleYear
Fulminant hepatic failure following halothane anaesthesia.
    Journal of clinical forensic medicine, 2005, Volume: 12, Issue:5

    Topics: Acute Kidney Injury; Adult; Anesthetics, Inhalation; Forensic Pathology; Halothane; Hand Injuries; H

2005
Acute hepatic coma treated by cross-circulation or exchange transfusion.
    The New England journal of medicine, 1967, Apr-27, Volume: 276, Issue:17

    Topics: Adult; Anesthesia, Inhalation; Blood Transfusion; Child; Exchange Transfusion, Whole Blood; Female;

1967
[Factors contributing development of acute hepatitis].
    Nihon rinsho. Japanese journal of clinical medicine, 1982, Volume: 40, Issue:4

    Topics: Acute Disease; Female; Halothane; Hepatic Encephalopathy; Hepatitis, Viral, Human; Humans; Infant, N

1982
Circulating immune complexes in patients with fulminant hepatic failure.
    Gut, 1981, Volume: 22, Issue:10

    Topics: Acetaminophen; Adolescent; Adult; Aged; Antigen-Antibody Complex; Chemical and Drug Induced Liver In

1981
An anesthetized model of lethal canine galactosamine fulminant hepatic failure.
    Hepatology (Baltimore, Md.), 1995, Volume: 21, Issue:3

    Topics: Anesthesia; Animals; Disease Models, Animal; Dogs; Galactosamine; Halothane; Hepatic Encephalopathy;

1995
[Liver transplantation in halothane-induced liver necrosis].
    Zentralblatt fur Chirurgie, 1994, Volume: 119, Issue:5

    Topics: Adult; Anesthesia, General; Appendectomy; Appendicitis; Chemical and Drug Induced Liver Injury; Halo

1994
Halothane-induced fulminant hepatic failure.
    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 1993, Volume: 12, Issue:3

    Topics: Halothane; Hepatic Encephalopathy; Humans; Liver Function Tests; Male; Middle Aged; Time Factors

1993
The uses of error: iatrogenic hepatitis.
    Lancet (London, England), 2001, Mar-10, Volume: 357, Issue:9258

    Topics: Aged; Anesthetics, Inhalation; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Female

2001
[Halothane and antituberculous drugs--a hepatotoxic combination? (author's transl)].
    Zeitschrift fur Gastroenterologie, 1977, Volume: 15, Issue:8

    Topics: Adult; Antitubercular Agents; Chemical and Drug Induced Liver Injury; Ethambutol; Female; Halothane;

1977
[Comparative study of 3 different technics of anesthesia in swine for isolated liver perfusion and for corssed circulation with heterotopic liver in experimental hepatic coma. Experiments on 140 animals].
    Minerva anestesiologica, 1976, Volume: 42, Issue:9

    Topics: Anesthesia, Inhalation; Animals; Enflurane; Evaluation Studies as Topic; Extracorporeal Circulation;

1976
Liver failure in the postoperative patient: the role of sepsis and immunologic deficiency.
    Surgery, 1975, Volume: 78, Issue:1

    Topics: Anesthetics; Bacterial Infections; Endotoxins; Escherichia coli Infections; Esophageal and Gastric V

1975
Exchange transfusion in hepatic coma: factors affecting results, with long-term follow-up data.
    American journal of surgery, 1975, Volume: 129, Issue:2

    Topics: Adolescent; Adult; Aged; Ammonia; Bilirubin; Biopsy; Chemical and Drug Induced Liver Injury; Child;

1975
Halothane associated hepatitis and phenobarbitone.
    The Journal of the Association of Physicians of India, 1989, Volume: 37, Issue:7

    Topics: Adult; Anesthesia, Obstetrical; Chemical and Drug Induced Liver Injury; Drug Synergism; Female; Halo

1989
Specific antibodies to halothane-induced liver antigens in halothane-associated hepatitis.
    British journal of anaesthesia, 1987, Volume: 59, Issue:10

    Topics: Adolescent; Adult; Aged; Antibodies; Antigens; Chemical and Drug Induced Liver Injury; Child; Child,

1987
Charcoal haemoperfusion in the treatment of fulminant hepatic failure.
    Lancet (London, England), 1974, Jun-29, Volume: 1, Issue:7870

    Topics: Adolescent; Adult; Amino Acids; Autopsy; Biopsy, Needle; Blood; Blood Cell Count; Blood Coagulation;

1974
Hepatic coma due to acute hepatic necrosis treated by exchange blood-transfusion.
    Lancet (London, England), 1967, Jul-22, Volume: 2, Issue:7508

    Topics: Aged; Anesthesia, Inhalation; Anuria; Electroencephalography; Exchange Transfusion, Whole Blood; Fem

1967
Peritoneoscopy during hepatic coma.
    Acta gastro-enterologica Belgica, 1973, Volume: 36, Issue:12

    Topics: Adolescent; Adult; Aged; Biopsy; Chemical and Drug Induced Liver Injury; Cholestasis; Female; Haloth

1973
[Exchange transfusion in the treatment of acute hepatic insufficiency].
    Minerva chirurgica, 1974, Sep-30, Volume: 29, Issue:18

    Topics: Acute Disease; Adolescent; Adult; Child; Child, Preschool; Exchange Transfusion, Whole Blood; Fatty

1974
Fulminant hepatic failure.
    Postgraduate medicine, 1973, Volume: 53, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Enzymes; Exchange Transfusion, Whole Blood; Halothane; Hepatic

1973
Histological appearances in fulminant hepatic failure with reference to aetiology, time of survival and role of immunological processes.
    Digestion, 1973, Volume: 8, Issue:1

    Topics: Acetaminophen; Adolescent; Adult; Aged; Cell Nucleus; Chemical and Drug Induced Liver Injury; Haloth

1973
Acute hepatic failure treated by cross circulation.
    Archives of internal medicine, 1973, Volume: 132, Issue:4

    Topics: Acute Disease; Adult; Anesthesia; Aspartate Aminotransferases; Bilirubin; Blood Donors; Blood Platel

1973
Editorial: Fulminant hepatic failure.
    JAMA, 1973, Dec-03, Volume: 226, Issue:10

    Topics: Age Factors; Aged; Anesthesia; Calcium; Chemical and Drug Induced Liver Injury; Exchange Transfusion

1973
Dopamine and serotonin metabolism in hepatic encephalopathy.
    British medical journal, 1974, Mar-23, Volume: 1, Issue:5907

    Topics: Acetaminophen; Acute Disease; Adult; Aged; Brain; Dopamine; Fatty Acids, Nonesterified; Female; Halo

1974
[Halothane hepatitis. 11 cases of hepatitis after repeated halothane anesthesia].
    Ugeskrift for laeger, 1974, Jan-14, Volume: 136, Issue:3

    Topics: Adult; Anesthesia; Chemical and Drug Induced Liver Injury; Child; Female; Halothane; Hepatic Encepha

1974
Chronic active hepatitis: possible adverse effect of exploratory laparotomy.
    Surgery, 1970, Volume: 68, Issue:5

    Topics: Adolescent; Anesthesia, Inhalation; Chronic Disease; Escherichia coli; Female; Halothane; Hepatic En

1970
A model which can be used to improve the treatment of acute hepatic failure.
    The British journal of surgery, 1972, Volume: 59, Issue:10

    Topics: Albumins; Anesthesia, General; Animals; Biotransformation; Blood Coagulation; Blood Pressure; Fibrin

1972
Acute massive hepatic necrosis with fatal liver failure.
    The American journal of digestive diseases, 1971, Volume: 16, Issue:9

    Topics: Acute Disease; Adolescent; Adult; Aged; Anticonvulsants; Antitubercular Agents; Azathioprine; Blood

1971
Pig-liver perfusion. Extracorporeal pig-liver perfusion in a patient with acute hepatic failure.
    Scandinavian journal of gastroenterology, 1971, Volume: 6, Issue:5

    Topics: Adult; Ammonia; Anesthesia, Inhalation; Animals; Autopsy; Bilirubin; Biopsy; Embolism; Female; Halot

1971
Hepatic necrosis associated with halothane anesthesia.
    The American journal of medicine, 1969, Volume: 47, Issue:5

    Topics: Anesthesia; Autopsy; Biopsy; Chemical and Drug Induced Liver Injury; Cholestasis; Collagen; Connecti

1969
Heterologous bovine liver perfusion therapy of acute hepatic failure.
    American journal of surgery, 1970, Volume: 119, Issue:2

    Topics: Adenosine Triphosphate; Adolescent; Adult; Animals; Cattle; Consciousness; Drug Hypersensitivity; Fe

1970
Exchange transfusion in hepatic coma. A review of 19 cases.
    The American journal of gastroenterology, 1971, Volume: 56, Issue:1

    Topics: Adolescent; Adult; Alanine Transaminase; Ammonia; Anesthesia, Inhalation; Autopsy; Bilirubin; Blood

1971
[Liver necrosis in consequence of fluothane anesthesia].
    Zentralblatt fur Chirurgie, 1967, Sep-23, Volume: 92, Issue:38

    Topics: Chemical and Drug Induced Liver Injury; Fatty Liver; Halothane; Hepatic Encephalopathy; Humans; Live

1967
Hepatic coma with renal failure, treated by repeated exchange transfusion.
    Archives of disease in childhood, 1968, Volume: 43, Issue:229

    Topics: Acute Kidney Injury; Adult; Aphasia; Arthrogryposis; Bilirubin; Calcium; Chemical and Drug Induced L

1968